This section addresses the scientific basis, engineering controls, validation strategy, and analytical verification required to manage endotoxin risk in regulated pharmaceutical manufacturing. It integrates pyrogen biology, endotoxin control within water and component preparation systems, depyrogenation equipment design, process qualification, and compendial testing technologies into a structured lifecycle framework. Emphasis is placed on risk-based control, documented validation evidence, and sustained assurance that endotoxin levels remain within defined product and regulatory limits.
Pyrogens are substances capable of producing a fever response when they enter the body through a clinically significant route. In pharmaceutical and medical-device manufacturing, pyrogen control is especially important for products administered parenterally, products contacting circulating blood, implantable products, and…
An endotoxin control strategy is the coordinated set of material, utility, equipment, process, environmental, analytical, and quality-system controls used to prevent unacceptable bacterial endotoxin from reaching a sterile product or product-contact surface. The strategy should prevent three related events: Finished-product…
Depyrogenation equipment is used to remove or inactivate pyrogenic contamination, particularly bacterial endotoxin, on pharmaceutical containers, components, tools, and product-contact equipment. For heat-resistant materials, high-temperature dry heat is the principal destructive method. A depyrogenation process is not defined by temperature…
Depyrogenation validation demonstrates that equipment and its defined operating process consistently provide the required thermal exposure and achieve the specified reduction of bacterial endotoxin under representative and worst-case conditions. The validation requires two independent but connected evidence streams: Neither evidence…
The Bacterial Endotoxins Test, commonly abbreviated BET, detects or quantifies bacterial endotoxin from Gram-negative bacteria. BET is used for pharmaceutical products, biological products, raw materials, process intermediates, water, medical-device extracts, and other samples for which an endotoxin requirement has been…
Endotoxin testing systems generate results used to evaluate pharmaceutical products, water, raw materials, process samples, and medical-device extracts against established bacterial endotoxin limits. For quantitative methods, the reported result may depend directly on incubation temperature, optical measurement, reaction timing, standard-curve…